Sotorasib in Advanced KRAS G12C-Mutated NSCLC: Results From the Global Expanded Access Program, Including Patients With Poor Performance Status and a History of CNS Metastases
索托拉西布治疗KRAS G12C突变型晚期非小细胞肺癌：来自全球扩大用药计划的结果，包括体能状态差和有中枢神经系统转移史的患者
期刊:JTO Clinical and Research Reports
影响因子:3.5
doi:10.1016/j.jtocrr.2026.100974
Novello, Silvia; Rabinovich, Natalie Maimon; Shih, Jin-Yuan; Pelizzari, Giacomo; Stevenson, James; Majem, Margarita; Ferreira, Carlos Gil; Petty, William J; Arriola, Edurne; Castagneris, Nicolas; De Castro, Javier; Morbeck, Igor; Bauman, Jessica; Toschi, Luca; Zer, Alona; Metro, Giulio; Kalmadi, Sujith; Martinez, Aitor Azkarate; Al Husaini, Hamed; Meloni, Alison R; Nduka, Chidozie; Ardito-Abraham, Christine; Xia, Caihong; Awad, Mark M
